| Drug Type Peptide drug conjugates | 
| Synonyms peptide-conjugated antisense oligonucleotide(Techulon), PPNA-40 | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Infection due to carbapenem resistant Acinetobacter | Preclinical | United States  | - | 





